About dr. reddys laboratories ltd - RDY
Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services and Active Ingredients, and Others. The Global Generics segment consists of manufacturing and marketing of prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name or as generic finished dosages with therapeutic equivalence to branded formulations. The Pharmaceutical Services and Active Ingredients segment focuses on manufacturing and marketing of active pharmaceutical ingredients and intermediates, also known as API, which are the principal ingredients for finished pharmaceutical products. The Others segment includes the operations of the subsidiary of the company. The company was founded by Kallam Anji Reddy on February 24, 1984 and is headquartered in Hyderabad, India.
RDY At a Glance
Dr. Reddy's Laboratories Ltd.
Door No. 8-2-337
Hyderabad, Telangana 500034
| Phone | 91-40-49002900 | Revenue | 3.85B | |
| Industry | Pharmaceuticals: Major | Net Income | 668.79M | |
| Sector | Health Technology | 2025 Sales Growth | 14.19% | |
| Fiscal Year-end | 03 / 2026 | Employees | 27,811 | |
| View SEC Filings |
RDY Valuation
| P/E Current | 17.258 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 16.428 |
| Price to Sales Ratio | 2.858 |
| Price to Book Ratio | 2.822 |
| Price to Cash Flow Ratio | 20.08 |
| Enterprise Value to EBITDA | 10.663 |
| Enterprise Value to Sales | 2.835 |
| Total Debt to Enterprise Value | 0.05 |
RDY Efficiency
| Revenue/Employee | 138,447.282 |
| Income Per Employee | 24,047.685 |
| Receivables Turnover | 3.349 |
| Total Asset Turnover | 0.739 |
RDY Liquidity
| Current Ratio | 1.918 |
| Quick Ratio | 1.373 |
| Cash Ratio | 0.444 |
RDY Profitability
| Gross Margin | 55.441 |
| Operating Margin | 21.35 |
| Pretax Margin | 23.52 |
| Net Margin | 17.37 |
| Return on Assets | 12.844 |
| Return on Equity | 18.413 |
| Return on Total Capital | 15.037 |
| Return on Invested Capital | 18.007 |
RDY Capital Structure
| Total Debt to Total Equity | 14.027 |
| Total Debt to Total Capital | 12.302 |
| Total Debt to Total Assets | 9.486 |
| Long-Term Debt to Equity | 2.359 |
| Long-Term Debt to Total Capital | 2.069 |